Explore more publications!
Reunion Technology Digest
Got News to Share?

Reunion Technology Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Reunion Technology Digest.

October 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30 31

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

Press releases published on December 29, 2025

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid
December 29, 2025

The AI Data Center Boom Goes Public: From “Neoclouds” to Power, Cooling, and the Grid

Indeterminate GlobeNewswire
Acronis Drives Security Momentum Through TRU Intelligence, Industry Recognition, and Platform Advancements
December 29, 2025

Acronis Drives Security Momentum Through TRU Intelligence, Industry Recognition, and Platform Advancements

Indeterminate GlobeNewswire
AITX's RAD RIO and ROSA Spotlighted on Cleveland TV Amid Downtown Safety Expansion
December 29, 2025

AITX's RAD RIO and ROSA Spotlighted on Cleveland TV Amid Downtown Safety Expansion

Indeterminate GlobeNewswire
SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)
December 29, 2025

SELLAS Life Sciences Provides Update on Pivotal Phase 3 REGAL Trial of Galinpepimut-S (GPS) in Acute Myeloid Leukemia (AML)

Indeterminate GlobeNewswire
VivoPower’s Tembo Achieves Key Business Combination Milestone for Nasdaq Listing: Submission of F-4 Registration to SEC on Confidential Basis as Revenue and Global Delivery Momentum Accelerates 
December 29, 2025

VivoPower’s Tembo Achieves Key Business Combination Milestone for Nasdaq Listing: Submission of F-4 Registration to SEC on Confidential Basis as Revenue and Global Delivery Momentum Accelerates 

Indeterminate GlobeNewswire
374Water Appoints Charles Weiser to Board of Directors
December 29, 2025

374Water Appoints Charles Weiser to Board of Directors

Indeterminate GlobeNewswire
Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta
December 29, 2025

Mereo BioPharma Announces Phase 3 ORBIT and COSMIC Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Indeterminate GlobeNewswire
IP Strategy Cancels $15 Million ELOC, Reinforcing Balance Sheet Strength and Reducing Related Dilution Risk
December 29, 2025

IP Strategy Cancels $15 Million ELOC, Reinforcing Balance Sheet Strength and Reducing Related Dilution Risk

Indeterminate GlobeNewswire
Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta
December 29, 2025

Ultragenyx Announces Phase 3 Orbit and Cosmic Results for Setrusumab (UX143) in Osteogenesis Imperfecta

Indeterminate GlobeNewswire
Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal
December 29, 2025

Branded Legacy, Inc. Announces Successful Retirement of Legacy Convertible Debt as New Management Focuses on Balance Sheet Optimization and OTC Yield Sign Removal

Indeterminate GlobeNewswire
Foresight Selected by Car Manufacturer Audi AG to Showcase its Terrain Intelligence Technology
December 29, 2025

Foresight Selected by Car Manufacturer Audi AG to Showcase its Terrain Intelligence Technology

Indeterminate GlobeNewswire
Genmab Portfolio Prioritization Update
December 29, 2025

Genmab Portfolio Prioritization Update

Indeterminate GlobeNewswire
Core AI Announces Divestiture of Siyata Mobile and Subsidiaries
December 29, 2025

Core AI Announces Divestiture of Siyata Mobile and Subsidiaries

Indeterminate GlobeNewswire
60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State
December 29, 2025

60 Degrees Pharmaceuticals Announces Detection of Babesia Infection in 24 Percent of Patients Presenting with Chronic Fatigue in Peer-Reviewed, Sponsored Study at NC State

Indeterminate GlobeNewswire
BiomX Announces $3.0 Million Private Placement
December 29, 2025

BiomX Announces $3.0 Million Private Placement

Indeterminate GlobeNewswire
Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum
December 29, 2025

Reviva to Present at the Sachs 9th Annual Neuroscience Innovation Forum

Indeterminate GlobeNewswire
Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
December 29, 2025

Theriva™ Biologics Announces Positive Scientific Advice from the European Medicines Agency (EMA) on the Design of a Phase 3 Trial of VCN-01 in Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)

Indeterminate GlobeNewswire
Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico
December 29, 2025

Theriva™ Biologics anuncia el asesoramiento científico favorable de la Agencia Europea de Medicamentos (EMA) sobre el diseño de un ensayo de fase III de VCN-01 en el adenocarcinoma ductal pancreático (ACDP) metastásico

Indeterminate GlobeNewswire
Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor
December 29, 2025

Praxis Precision Medicines Announces the FDA Has Granted Breakthrough Therapy Designation for Ulixacaltamide HCl in Essential Tremor

Indeterminate GlobeNewswire
CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year
December 29, 2025

CareCloud Appoints Chief Strategy Officer to Lead Enterprise AI Platform as Company Enters 2026 as Its Defining AI Year

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions